Psilocybin and LSD for more neurons

Neurochemistry and BDNF

BDNF stands for Brain Derived Neurotrophic Factor and is a protein that stimulates the growth and survival of nerve cells in the brain. Both psilocybin and LSD are known to increase the release of BDNF. This is because these substances bind to serotonin receptors in the brain, creating a chain reaction that leads to the release of BDNF.

When BDNF is released, it stimulates the growth of new nerve cells and synapses in the brain. This can lead to improved cognitive functions, such as memory and learning ability. BDNF has also been shown to help treat depression, anxiety and addiction disorders.

It is not yet fully understood exactly how psilocybin and LSD work in the brain, but the increase in BDNF is one of the promising effects that have contributed to research into the therapeutic potential of these drugs.

psilocybine onderzoek -Neuroplasticiteit en psychedelica

Glutamate also helps

Glutamate is an important neurotransmitter found throughout the brain and implicated in various neuropsychiatric disorders. It also plays a crucial role in neuroplasticity, which refers to the brain's ability to reorganize itself and adapt to changing environments. Glutamate activates N-methyl-D-aspartate (NMDA) receptors, leading to changes in synaptic transmission and the eventual formation of new synapses in the brain. It also increases the expression of growth factors such as the aforementioned BDNF, which contributes to the survival and growth of neurons. At the right place in the brain, such as in the hippocampus, glutamate thus plays an important role in learning, memory and overall neuroplasticity. However, excess glutamate can lead to hyperexcitability of neurons and neurotoxicity, which can lead to various neurological disorders such as stroke and epilepsy.

5HT2a receptor

The transformation of gene expression in various brain cells is triggered by the interaction of psychedelics such as psilocybin and LSD, which have a strong affinity for 5HT2a receptors. The resulting increase in the release of BDNF and glutamate further alters the physiological state of the brain, contributing to the various effects of these substances. More aspects come into play when using substances such as psilocybin.

psilocybine en 5htp receptor -Neuroplasticiteit en psychedelica

Psychedelics against neurodegenerative disorders?

Psilocybin and psychedelics have potential therapeutic uses in neurodegenerative disorders such as multiple sclerosis (MS) and Parkinson's disease. This is because these substances can increase neuroplasticity, which allows the brain to adapt and create new connections. Neuroplasticity is the brain's ability to adapt and change by creating new neural networks or strengthening existing ones. In neurodegenerative diseases, the brain is damaged and these mechanisms can be impaired. This can lead to symptoms such as tremors, stiffness and difficulty moving.

Studies have shown that treatments with psilocybin and psychedelics can increase neuroplasticity and even create new neural connections. This can lead to improvement in symptoms and improvement in overall quality of life in patients with neurodegenerative diseases. Although more research is needed to determine the effectiveness and safety of these treatments, psilocybin and psychedelics offer hope for people with neurodegenerative disorders who currently struggle with limited options for treatment and improvement of their symptoms.

Neuroplasticity in depression

Research has shown that increased neuroplasticity can help alleviate depression because it can lead to a reconfiguration of the reward and emotion system in the brain. In people with depression, this system is often disrupted. Through increased neuroplasticity, new neuronal pathways can be formed that help repair this dysfunction. In theory and according to several scientific studies, psychedelics such as psilocybin and LSD can help with depression.

New neuroconfiguration against anxiety symptoms

Achieving a new neuroconfiguration is a consequence of psychedelic therapy and involves retraining the brain to better cope with anxiety symptoms. The idea is that anxiety symptoms arise from wrong patterns in the brain, which can be changed by learning new, healthy patterns. The best results are achieved when these techniques are applied in the limbic system, the part of the brain responsible for emotions, motivation and memory. This area is crucial in the development and maintenance of anxiety symptoms. An altered neuroconfiguration can be effective for people who suffer from anxiety symptoms and can help them feel more calm and relaxed in everyday life again.

Ready for a psychedelic session?

Psychedelic sessions are not suitable for everyone, and there are several contraindications that should be considered before deciding to participate in a psychedelic experience. Individuals with a history of mental illness such as schizophrenia, bipolar disorder, or psychotic episodes should exercise caution when using psychedelics. Persons with a history of cardiovascular disease, high blood pressure, liver or kidney disease should also exercise caution when using psychedelics. In addition, individuals taking medications such as antidepressants, antipsychotics, or blood pressure lowering drugs should exercise caution when using psychedelics because of potential drug interactions. Finally, pregnant and breastfeeding women should avoid using psychedelics because of potential negative effects on the baby. Therefore, it is important to check carefully if you are able to do a psychedelic session. Please use the intake below so we can screen for known contraindications to substances such as MDMA, LSD, psilocybin and psilohuasca (psiloflora).